期刊文献+

糖尿病足腔内治疗后动脉再闭塞的处理

Management of arterial reocclusion after endovascular treatment for diabetic feet
原文传递
导出
摘要 目的 总结糖尿病足患者腔内治疗后动脉再闭塞的原因及治疗方法.方法 回顾性分析天津市第一中心医院2009年1月1日至2013年10月1日收治的371例糖尿病足腔内治疗后动脉再闭塞患者的病因、治疗方法等临床资料.结果 首次腔内治疗时按照泛大西洋协作组织(Trans-Alantic Inter-Society Consensus,TASC)Ⅱ分级:A级37例、B级85例、C级143例、D级106例.再次闭塞时间为1d至36个月,平均(21±8)个月.再闭塞的原因:内膜增生263例(70.9%)、血栓形成65例(17.5%)、夹层形成19例(5.1%)、支架断裂17例(4.6%)、血管破裂7例(1.9%).再闭塞后给予再次腔内治疗327例(88.1%),动脉旁路手术23例(6.2%),保守治疗13例(3.5%),直接截肢(截趾)4例(1.1%),围手术期死亡4例(1.1%).共随访275例患者,随访时间1~ 36个月,平均(13±8)个月.6、12、24个月的血管通畅率分别为82.9%、71.3%、63.0%,截肢率分别为1.1%、1.8%、2.5%.结论 内膜增生是造成糖尿病足腔内治疗后动脉再闭塞的主要原因.多数患者可再次腔内治疗,近期通畅率较高. Objective To investigate the causes of arterial reocclusion in diabetic feet patients after endovascular treatment and its remedial measures.Methods From January 2009 to October 2013,clinical data of 371 arterial reocclusion of diabetic feet patients after endovascular treatment in Tianjin First Central Hospital were reviewed retrospectively.We summarized the causes of reocclusion,treatment methods and the short term results.Results According to the Trans-Alantic Inter-Society Consensus (TASC) Ⅱ grading standards,the first time when the endovascular treatment started there were 37 cases of grade A,85 cases of grade B,143 cases of grade C,106 cases of grade D.Arterial re-occlusion developed from one day to 36 months,averaging at (21 ± 8) months.Causes of re-occlusion included intimal hyperplasia in 263 cases (70.9%),thrombosis in 65 cases (17.5%),dissection in 19 cases (5.1%),stent fracture in 17 cases (4.6%),vascular rupture in 7 cases (1.9%).Remedial therapy adopted for arterial reocclusion was repeated endovascular treatment in 327 cases (88.1%),arterial bypass surgery in 23 cases (6.2%),conservative treatment in 13 cases (3.5%),amputation (cut toe) in 4 cases (1.1%),4 cases (1.1%) died perioperatively.275 cases were followed up for 1 to 36 months,the average was (13 ± 8) months.patency rate was 82.9%,71.3% and 63.0% at 6 months,1 year and 2 years.Amputation rate was 1.1%,1.8% and 2.5% at 6 months,1 year and 2 years.Conclusions Intimal hyperplasia is to blame for arterial reocclusion after endovascular treatment of diabetic foot.In this case most patients still can benefit from second time endovascular treatment,with a satisfactory short term patency rate.
出处 《中华普通外科杂志》 CSCD 北大核心 2014年第12期905-907,共3页 Chinese Journal of General Surgery
关键词 糖尿病足 血管成形术 手术后并发症 内膜增生 Diabetic foot Angioplasty Postoperative complications Intimal hyperplasia
作者简介 通信作者:何菊,E-mail:hejutian@163.com
  • 相关文献

参考文献10

  • 1Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II ) [J]. J Vasc Surg, 2007,45:(Suppl S):S5-67.
  • 2Bown M J, Bolia A, Sutton AJ. Subintimal angioplastv meta- analytieal evidence of clinical utility [ J]. Eur J Vasc Endovasc Surg, 2009,38 ( 3 ) : 323-337.
  • 3Gargiulu M, Maioli F, Ceccacci T, et al. What's next alter optimal infrapopliteal angioplasty? clinical and uhrasonographie results of a prospective single-center study[J]. J Endovase Ther, 2008,15 ( 3 ) : 363-369.
  • 4Lyden SP. Techniques and outcomes for endovaseular treatment in the tibial arteries[J]. J Vase Surg,2009,50(5) :1219-1223.
  • 5宋希涛,刘暴,叶炜,郑月宏,李拥军,刘昌伟.糖尿病对股腘动脉腔内治疗预后的影响[J].中国微创外科杂志,2013,13(9):780-784. 被引量:4
  • 6Park JY, Jeon YS, Cho SG, et al. Stent fractures after superficial femoral artery stenting[ J ], J Korean Surg Soc,2012, 83(3) :183-186.
  • 7谷涌泉,张建,俞恒锡,李建新,齐立行,李学锋,郭连瑞,崔世军,罗涛,陈兵,齐一侠,吴英锋,佟铸,汪忠镐.膝下动脉腔内成形术治疗严重下肢缺血[J].中华普通外科杂志,2007,22(2):123-125. 被引量:63
  • 8MeKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions [ J ]. Ann Surg, 2008,248 ( g ) : 519- 528.
  • 9Shammas NW, Shammas GA, ttelou TJ,et al. Safely and 1-year revascularization outeome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center [ Jl. CaMiovase Revase Med,2012, 13(4) :224-227.
  • 10Yongquan G, Lianrui G, Lixing Q, et al. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter[J].Int Angiol, 2013,32(4) :362-367.

二级参考文献23

  • 1齐立行,谷涌泉,俞恒锡,李学峰,崔世军,郭连瑞,李建新,张建,汪忠镐.糖尿病性和非糖尿病性动脉硬化下肢血管造影特点比较及其临床意义[J].中华糖尿病杂志(1006-6187),2005,13(6):412-413. 被引量:96
  • 2谷涌泉,张建,李建新,廖传军,汪忠镐.血管内超声消融治疗下肢缺血4例报告[J].中华老年多器官疾病杂志,2005,4(4):315-316. 被引量:6
  • 3谷涌泉,张建,郭连瑞,李建新,俞恒锡,齐立行,李学锋,崔世军,罗涛,汪忠镐.下肢小腿动脉介入治疗糖尿病足坏疽二例[J].中华普通外科杂志,2006,21(4):312-312. 被引量:9
  • 4Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia:angiographic and clinical results. J Vasc Interv Radiol, 2000,11:1021-1031.
  • 5Boyer L, Therre T, Garcier JM, et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol,2000 ,41:73-77.
  • 6Lofberg AM, Lorelius LE, Karacagil S, et al. The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol, 1996,19:317-322.
  • 7Brillu C, Picquet J, Villapadierna F, et al. Percutaneous transluminal angioplasty for management of critical ischemia in arteries below the knee. Ann Vasc Surg, 2001,15:175-181.
  • 8Bakal CW, Sprayregen S, Scheinbaum K, et al. Percutaneous transluminal angioplasty of the infrapopliteal arteries: results in 53 patients. Am J Roentgenol, 1990,154 : 171-174.
  • 9Brown KT, Schoenberg NY, Moore ED, et al. Percutaneous transluminal angioplasty of infrapopliteal vessels: preliminary results and technical considerations. Radiology, 1988,169:75-78.
  • 10Schwarten DE. Clinical and anatomical considerations for nonoperative therapy in tibial disease and the results of angioplasty. Circulation, 1991,83 : 186 -190.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部